Okyo PharmaOKYO
13F holders, Q2 2025 (June 30)5holders −2
2new positions
4sold out
$0.53avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Okyo Pharma Ltd. (OKYO) in their 13F filings, down 2 from Q1 2025. 2 opened new positions and 4 sold out. The largest holders were Dauntless Investment Group, LLC ($1.4M), Cerity Partners LLC ($33K) and Geode Capital Management, LLC ($31K).
- Company
- Okyo Pharma Ltd.
- CUSIP
- G6724L116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $28K |
| Exits | 4 | $78K |
All 13F filers, Q1 2025 → Q2 2025: 757,115 shares bought and 61,400 shares sold, net +695,715 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Dauntless Investment Group, LLC | 6.52% | Add +37.6% | 2,735,780 | $1.4M |
| Cerity Partners LLC | 0.00% | No change | 12,812 | $33K |
| Geode Capital Management, LLC | 0.00% | No change | 12,090 | $31K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | New | 10,000 | $28K |
| UBS Group AG | 0.00% | New | 115 | $296 |
"% of holder's portfolio" is OKYO's weight in each manager's 13F, not the share of Okyo Pharma Ltd. the manager owns.